✦ LIBER ✦

Impact of genetic and acquired alteration in cytochrome P450 system on pharmacologic and clinical response to clopidogrel

✍ Scribed by Terry K.W. Ma; Yat-Yin Lam; Victoria P. Tan; Thomas J. Kiernan; Bryan P. Yan

Book ID: 113846006
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 474 KB
Volume: 125
Category: Article
ISSN: 0163-7258
DOI: 10.1016/j.pharmthera.2009.10.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-5: Impact of Cytochrome P450 2C19 an

TCT-5: Impact of Cytochrome P450 2C19 and ABCB1 Genotypes on Post-Clopidogrel Platelet Reactivity and Clinical Outcome

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 245 KB

Genotypes of cytochrome P450 and clinica

Genotypes of cytochrome P450 and clinical response to clomipramine in patients with major depression

✍ J Bouchez; V Dumur; M Lhermitte; M Goudemand 📂 Article 📅 1995 🏛 Elsevier Science 🌐 French ⚖ 231 KB

Biological effect of increased maintenan

Biological effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19⁎2 allele on clopidogrel responsiveness

✍ Pierre Fontana; David Senouf; François Mach 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 159 KB

019 Effect of increased maintenance dose

019 Effect of increased maintenance dose of clopidogrel in cardiovascular outpatients and influence of the cytochrome P450 2C19 *2 allele on clopidogrel responsiveness

✍ Abid, Leila; Laroussi, Lobna; Abdelmoula, Nouha; Abdelhédi, Rania; Kharrat, Najl 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 103 KB

Altered induction response of hepatic cy

Altered induction response of hepatic cytochrome P-450 to phenobarbital, 3-methylcholanthrene, and β-naphthoflavone in organotin-treated animals

✍ Daniel W. Rosenberg; Mohinder K. Sardana; Attallah Kappas 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 967 KB

Cytochrome P450 pharmacogenetics as a pr

Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis

✍ Kazuki Takada; Million Arefayene; Zeruesenay Desta; Cheryl H. Yarboro; Dimitrios 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

## Abstract ## Objective Pulse cyclophosphamide is the treatment of choice for severe lupus nephritis. However, not all patients respond to this therapy, and gonadal toxicity is of particular concern. Cyclophosphamide is a prodrug that requires activation by cytochrome P450 (CYP) enzymes. We condu